REQUEST A DEMO
Total
USD $0.00
Search more companies

China Sxt Pharmaceuticals Inc. (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: China Sxt Pharmaceuticals Inc. Profile Updated: May 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

China SXT Pharmaceuticals, Inc. is a pharmaceutical company. The company focuses on the research, development, manufacture, and sales of Traditional Chinese Medicine Pieces, including Advanced TCMP. They are known for their pharmaceutical beverage products and are listed on NASDAQ under the symbol SXTC. The company operates through subsidiaries in the PRC and various variable interest entities, and they are a specialty pharmaceutical company focusing on the research, development, and production of medicinal drinks products.

Headquarters
178 Taidong Rd North
Taizhou; Zhejiang; Postal Code: 225300

Contact Details: Purchase the China Sxt Pharmaceuticals Inc. report to view the information.

Website: http://www.sxtchina.com

Basic Information
Total Employees:
Purchase the China Sxt Pharmaceuticals Inc. report to view the information.
Outstanding Shares:
Purchase the China Sxt Pharmaceuticals Inc. report to view the information.
Financial Auditors:
Purchase the China Sxt Pharmaceuticals Inc. report to view the information.
Incorporation Date:
2017
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
12.19%
Purchase this report to view the information.
11.5%
Purchase this report to view the information.
0.75%
Subsidiaries
China Sxt Group Limited (Hong Kong SAR, China)
Jiangsu Su Xuan Tang Pharmaceutical Co. Ltd.
Taizhou Su Xuan Tang Biotechnology, Co. Ltd.
Company Performance
Financial values in the chart are available after China Sxt Pharmaceuticals Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-2.23%
Total operating revenue
-2.23%
Operating profit (EBIT)
53.19%
EBITDA
64.72%
Net Profit (Loss) for the Period
47.78%
Total assets
-21.75%
Total equity
-5.18%
Operating Profit Margin (ROS)
144.25%
Net Profit Margin
140.22%
Return on Equity (ROE)
18.15%
Debt to Equity Ratio
-6.17%
Quick Ratio
0.2%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?